JP5140741B2 - 能動薬物放出型サーモロッドの製造方法およびそのサーモロッド - Google Patents
能動薬物放出型サーモロッドの製造方法およびそのサーモロッド Download PDFInfo
- Publication number
- JP5140741B2 JP5140741B2 JP2010544877A JP2010544877A JP5140741B2 JP 5140741 B2 JP5140741 B2 JP 5140741B2 JP 2010544877 A JP2010544877 A JP 2010544877A JP 2010544877 A JP2010544877 A JP 2010544877A JP 5140741 B2 JP5140741 B2 JP 5140741B2
- Authority
- JP
- Japan
- Prior art keywords
- thermorod
- drug
- active drug
- iron
- shape
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
また、前記高分子物質はポリエチレン酢酸ビニル(polyethylene-co-vinyl acetate)であることが好ましい。
ここで、前記能動薬物放出型サーモロッドは温度に応じて薬物放出速度が制御されることが好ましい。
前記一定の直径および長さに二相ステンレス鋼が加工されると、前記二相ステンレス鋼の表面に薬物混合層を形成させる薬物混合試片を製造する。
<PEVAの化学構造>
<PBMAの化学構造>
20:薬物混合層
30:コーティング層
Claims (12)
- 誘導磁場内で渦電流損失とヒステリシス損失によって熱を発生させる能動薬物放出型サーモロッドの製造方法において、
誘導磁場によって発熱する金属又は非金属物質で製作されたサーモロッドを一定の形状に加工する第1段階と、
薬物と前記薬物の支持体の役割を果たす高分子物質とを混合して薬物混合試片を製造する第2段階と、
前記薬物混合試片を用いて前記サーモロッドの表面に薬物混合層を形成する第3段階と、
前記薬物混合層の表面に、コーティング層をさらに形成する第4段階とを含む、
能動薬物放出型サーモロッドの製造方法。 - 前記サーモロッドは、鉄、ステンレス鋼、二相ステンレス鋼、ニッケル−銅合金、鉄−ニッケル合金、パラジウム−コバルト合金、鉄−クロム合金、および鉄−コバルト合金よりなる群から選ばれたいずれか一つで構成されることを特徴とする請求項1に記載の能動薬物放出型サーモロッドの製造方法。
- 前記サーモロッドは、線状、板状、コイル状、およびチューブ状よりなる群から選ばれたいずれか一つの形状に加工されることを特徴とする請求項1又は2に記載の能動薬物放出型サーモロッドの製造方法。
- 前記高分子物質は、ポリエチレン酢酸ビニル(polyethylene-co-vinyl acetate)であることを特徴とする請求項1〜3いずれかに記載の能動薬物放出型サーモロッドの製造方法。
- 前記コーティング層は、テトラヒドロフランにポリエチレン酢酸ビニル、ポリイソブチルメタクリレート、またはこれらの混合物を溶解させた浸漬コーティング溶液から形成されることを特徴とする請求項1〜4いずれかに記載の能動薬物放出型サーモロッドの製造方法。
- 前記サーモロッドは、二相ステンレス鋼を用いて製作されたサーモロッドである、請求項1〜5いずれかに記載の能動薬物放出型サーモロッドの製造方法。
- 誘導磁場内で渦電流損失とヒステリシス損失によって熱を発生させる能動薬物放出型サーモロッドにおいて、
薬物と前記薬物の支持体の役割を果たす高分子物質とを混合した薬物混合試片を、誘導磁場によって発熱する金属又は非金属物質で製作されたサーモロッドの表面にコーティングして薬物混合層を形成したこと、及び
前記薬物混合層の表面に、コーティング層をさらに形成したことを特徴とする、
能動薬物放出型サーモロッド。 - 前記サーモロッドは、鉄、ステンレス鋼、二相ステンレス鋼、ニッケル−銅合金、鉄−ニッケル合金、パラジウム−コバルト合金、鉄−クロム合金、および鉄−コバルト合金よりなる群から選ばれたいずれか一つで構成されることを特徴とする請求項7に記載の能動薬物放出型サーモロッド。
- 前記サーモロッドは、線状、板状、コイル状、およびチューブ状よりなる群から選ばれたいずれか一つの形状に加工されることを特徴とする請求項7又は8に記載の能動薬物放出型サーモロッド。
- 前記高分子物質は、ポリエチレン酢酸ビニル(polyethylene-co-vinyl acetate)であることを特徴とする請求項7〜9いずれかに記載の能動薬物放出型サーモロッド。
- 前記コーティング層は、テトラヒドロフランにポリエチレン酢酸ビニル、ポリイソブチルメタクリレート、またはこれらの混合物を溶解させた浸漬コーティング溶液から形成されることを特徴とする請求項7〜10いずれかに記載の能動薬物放出型サーモロッド。
- 前記能動薬物放出型サーモロッドは、温度に応じて薬物放出速度が制御されることを特徴とする請求項7〜11いずれかに記載の能動薬物放出型サーモロッド。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2008-0047988 | 2008-05-23 | ||
KR1020080047988A KR101104901B1 (ko) | 2008-05-23 | 2008-05-23 | 능동 약물 방출형 서모 로드의 제조방법 및 이에 의해제조된 서모 로드 |
PCT/KR2008/006356 WO2009142366A1 (en) | 2008-05-23 | 2008-10-29 | Manufacturing method of thermo-rod for active drug release the thermo-rod |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011510736A JP2011510736A (ja) | 2011-04-07 |
JP5140741B2 true JP5140741B2 (ja) | 2013-02-13 |
Family
ID=41340285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010544877A Expired - Fee Related JP5140741B2 (ja) | 2008-05-23 | 2008-10-29 | 能動薬物放出型サーモロッドの製造方法およびそのサーモロッド |
Country Status (6)
Country | Link |
---|---|
US (1) | US8906391B2 (ja) |
EP (1) | EP2276476A4 (ja) |
JP (1) | JP5140741B2 (ja) |
KR (1) | KR101104901B1 (ja) |
CN (1) | CN101969935B (ja) |
WO (1) | WO2009142366A1 (ja) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0226565A (ja) * | 1988-07-18 | 1990-01-29 | Olympus Optical Co Ltd | 薬剤徐放基材 |
US5401377A (en) * | 1993-08-06 | 1995-03-28 | Biomedix, Inc. | Ion-selective sensor with polymeric membrane having phospholipid dispersed therein |
US5643246A (en) * | 1995-02-24 | 1997-07-01 | Gel Sciences, Inc. | Electromagnetically triggered, responsive gel based drug delivery device |
US8029561B1 (en) | 2000-05-12 | 2011-10-04 | Cordis Corporation | Drug combination useful for prevention of restenosis |
AU2002249826A1 (en) | 2000-12-22 | 2002-07-30 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
JP2002253683A (ja) | 2000-12-29 | 2002-09-10 | Shine Co Ltd | 人体に差し込まれる自励式発熱インプラント |
US7438925B2 (en) | 2002-08-26 | 2008-10-21 | Biovention Holdings Ltd. | Drug eluting coatings for medical implants |
GB0222612D0 (en) * | 2002-09-30 | 2002-11-06 | Univ Gent | Controlled delivery system for bioactive substances |
EP1653865A2 (en) * | 2003-05-23 | 2006-05-10 | Angiotech International Ag | Anastomotic connector devices |
US7727969B2 (en) * | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
KR100506543B1 (ko) * | 2003-08-14 | 2005-08-05 | 주식회사 제닉 | 온도 감응성 상태변화 하이드로겔 조성물 및 그 제조방법 |
KR20060025648A (ko) * | 2004-09-17 | 2006-03-22 | 보령제약 주식회사 | 개별 단위형 서방성 과립의 제조방법 및 그로부터 제조된의약 조성물 |
JP5756588B2 (ja) | 2005-07-15 | 2015-07-29 | ミセル テクノロジーズ、インコーポレイテッド | 制御されたモルホロジーの薬剤粉末を含むポリマーコーティング |
US20070191816A1 (en) * | 2006-02-13 | 2007-08-16 | Boston Scientific Scimed, Inc. | Radio frequency induced drug elution |
KR100668046B1 (ko) * | 2006-03-15 | 2007-01-16 | 한국화학연구원 | 생체적합성 및 온도감응성의 폴리에틸렌글리콜/폴리에스터블록 공중합체 및 이의 제조방법 |
KR100774613B1 (ko) * | 2006-05-26 | 2007-11-12 | 한국화학연구원 | 수불용성 고분자로 이루어진 서방형 약물 전달체 |
-
2008
- 2008-05-23 KR KR1020080047988A patent/KR101104901B1/ko active IP Right Grant
- 2008-10-29 WO PCT/KR2008/006356 patent/WO2009142366A1/en active Application Filing
- 2008-10-29 CN CN2008801277118A patent/CN101969935B/zh not_active Expired - Fee Related
- 2008-10-29 JP JP2010544877A patent/JP5140741B2/ja not_active Expired - Fee Related
- 2008-10-29 EP EP08874399A patent/EP2276476A4/en not_active Withdrawn
-
2010
- 2010-10-20 US US12/908,686 patent/US8906391B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20110034871A1 (en) | 2011-02-10 |
EP2276476A1 (en) | 2011-01-26 |
KR101104901B1 (ko) | 2012-01-12 |
JP2011510736A (ja) | 2011-04-07 |
CN101969935B (zh) | 2012-09-26 |
WO2009142366A1 (en) | 2009-11-26 |
CN101969935A (zh) | 2011-02-09 |
KR20090121865A (ko) | 2009-11-26 |
US8906391B2 (en) | 2014-12-09 |
EP2276476A4 (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fathi Karkan et al. | Magnetic nanoparticles in cancer diagnosis and treatment: a review | |
Mitsumori et al. | Development of intra-arterial hyperthermia using a dextran-magnetite complex | |
CN102379762B (zh) | 一种带凹槽的生物可降解支架及其制备方法 | |
US6673104B2 (en) | Magnetic stent | |
Munaweera et al. | Chemoradiotherapeutic magnetic nanoparticles for targeted treatment of nonsmall cell lung cancer | |
Rosengart et al. | Magnetizable implants and functionalized magnetic carriers: A novel approach for noninvasive yet targeted drug delivery | |
EP3454737B1 (en) | Tumor bed implant for multimodality treatment of at risk tissue surrounding a resection cavity | |
WO2000066192A1 (de) | Stent zur offenhaltung gangartiger strukturen | |
DE10113659B4 (de) | Metallischer medizinischer Stent | |
Grillone et al. | Magnetic nanotransducers in biomedicine | |
EP1594571B1 (en) | Microparticles for selectively targeted hyperthermia | |
Tiwari et al. | The combined effect of thermal and chemotherapy on HeLa cells using magnetically actuated smart textured fibrous system | |
Ahmed et al. | Closed‐Loop Temperature‐Controlled Magnetic Hyperthermia Therapy with Magnetic Guidance of Superparamagnetic Iron‐Oxide Nanoparticles | |
Park et al. | The induction of hyperthermia in rabbit liver by means of duplex stainless steel thermoseeds | |
Tucker | Use of interstitial temperature self-regulating thermal rods in the treatment of prostate cancer | |
JP5140741B2 (ja) | 能動薬物放出型サーモロッドの製造方法およびそのサーモロッド | |
Brezovich et al. | Hyperthermia of pet animal tumours with self-regulating ferromagnetic thermoseeds | |
TUCKER et al. | Use of permanent interstitial temperature self-regulating rods for ablation of prostate cancer | |
US10661092B2 (en) | Mixture of lafesih magnetic nanoparticles with different curie temperatures for improved inductive heating efficiency for hyperthermia therapy | |
Du et al. | Effect of local hyperthermia induced by nanometer magnetic fluid on the rabbit VX2 liver tumor model | |
Goren et al. | Targeting tumor cells using magnetic nanoparticles–a feasibility study in animal models | |
Kawashita | Development and evaluation of the properties of functional ceramic microspheres for biomedical applications | |
Zhao et al. | Magnetic nanocomposite devices for cancer thermochemotherapy | |
Powar | Development status in the meadow of nanostructure magnetic drug delivery system and its promising applications | |
Hilger | Smart Nanoparticles and the Effects in Magnetic Hyperthermia In Vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120315 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120404 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120625 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121030 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121119 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5140741 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151122 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |